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Abstract The purpose of this investigation was to describe a
distribution of cytomegalovirus (CMV) single and multiple
genotypes among infected pregnant women, their fetuses, and
newborns coming from Central Poland, as well as congenital
cytomegaly outcome. The study involved 278 CMV-
seropositive pregnant women, of whom 192 were tested for
viral DNAemia. Human cytomegalovirus (HCMV) genotyp-
ing was performed for 18 of 34 pregnant women carrying the
viral DNA and for 12 of their 15 offspring with confirmed
HCMV infections. Anti-HCMV antibodies levels were
assessed by chemiluminescence immunoassay (CLIA) and
enzyme-linked fluorescence assay (ELFA) tests. Viral DNA
loads and genotypes were determined by real-time polymerase
chain reaction (PCR) assays for the UL55 gene. In the
pregnant women, we identified HCMV gB1, gB2, gB3, and
gB4 genotypes. Single gB2, gB3, or gB4 genotypes were
observed in 14 (77.8 %) women, while multiple gB1–gB2
or gB2–gB3 genotypes were observed in four (22.2 %).
Maternal HCMV genotypes determined the genotypes identi-
fied in their fetuses and newborns (p≤0.050). Half of them
were infected with single HCMVgB1, gB2, or gB3 genotypes
and the other half with multiple gB1–gB2 or gB2–gB3 geno-
types. Single and multiple genotypes were observed in both
asymptomatic and symptomatic congenital cytomegaly, al-
though no gB3 genotype was identified among asymptomatic
cases. In Central Poland, infections with single and multiple
HCMV strains occur in pregnant women, as well as in their
fetuses and neonates, with both asymptomatic and symptom-
atic infections. HCMV infections identified in mothers seem
to be associated with the viral genotypes in their children.
Introduction
Human cytomegalovirus (HCMV) is the most common cause
of intrauterine infections worldwide [1–5]. Nucleotide vari-
ability was determined for approximately 20 open reading
frames (ORFs) of HCMV that encode, e.g., viral envelope
glycoproteins B (gB, UL55), H (gH, UL75), and N (gN,
UL73), as well as chemokines and chemokine receptors, like
a tumor necrosis factor (TNF)-α receptor (pUL144, UL144)
[6–9]. Although sequence variability in the large genome
generates extensive viral strain diversity, the clinical signifi-
cance of HCMV genotypes remains rather unknown.
Glycoprotein B is the major HCMV envelope protein that
has been determined as an important factor for viral in vivo
and in vitro replication, as well as for host cell entry, cell-to-
cell virus transmission, and fusion of infected cells [4, 10–12].
The gB polypeptide, composed of 906 amino acids, is trans-
lated into a 160-kDa precursor molecule that is cleaved at
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position 460 by cellular endoprotease to produce the N- and
C- terminal products [11, 13, 14]. The cleavage site and the
region between 448 and 481 codons were described as the
area of the highest genetic variability [11, 14]. Considering
this highly polymorphic site, four main HCMV genotypes,
gB1, gB2, gB3, and gB4, and three rare non-prototypic vari-
ants, gB5, gB6, and gB7, were defined [11, 14]. A recent
study, performed in newborns from Central Poland showed
UL55 gB2 as the most prevalent genotype of HCMV (96 %)
[4]. In contrast, an earlier study performed in infants and
newborns from Southern Poland demonstrated gB1 (63.5 %)
as the most common genotype [14].
Some researchers have also reported relationships between
HCMV genotypes and the development and outcome of
cytomegaly, observed in human immunodeficiency virus (HIV)-
infected patients, hematopoietic transplant recipients, as well as in
congenitally infected fetuses and newborns [15–17]. However,
some reports indicated no association between gB genotypes and
cytomegaly severity in either fetuses or newborns [18–21].
In this study, we determined the gB genotypes of HCMVin
pregnant Polish women, infected during pregnancy, as well as
in their fetuses and newborns with confirmed congenital in-
fections. Moreover, we investigated if any coinfections with
different HCMV genotypes might have occurred in the ana-
lyzed groups coming from Central Poland. The primary goal
of our studywas to search for viral genotypes transmitted from
mother to fetus through the placenta. The secondary goal
included an attempt to describe the relationship between the
occurrence of mixed infections and cytomegaly outcomes.
Materials and methods
The study group consisted of 278 CMV-seropositive pregnant
women admitted to the Department of Fetal-Maternal
Medicine and Gynecology at the Polish Mother’s Memorial
Hospital Research Institute in Lodz between September 2009
and July 2013 (see Figure 1). Of the total study population, 192
women were tested for HCMV DNAemia. The presence of
viral DNAwas determined for 34 examined patients. Among
the fetuses and newborns of mothers carrying HCMV DNA,
the viral load was studied for 23 cases, of which 15 were viral
DNA-positive. The isolated HCMV DNA solutions enabled
viral genotyping in 18 pregnant women, as well as in their 12
offspring with confirmed HCMV infections. For two out of all
fetal cases, we acquired further data on the viral genotype
status, determined also at their postnatal stage. Six fetuses
and one newborn presented with symptomatic congenital
cytomegaly. Of the symptomatic fetuses, three were fatal cases.
The asymptomatic cytomegaly in fetuses and newborns was
Fig. 1 Distribution of pregnant
women, their fetuses, and
newborns included in the
serological testing for human
cytomegalovirus (HCMV)
infections and genotyping of the
virus
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determined in case of the lack of any ultrasound symptoms
related to the disease, while the symptomatic cytomegaly was
determined in case of the occurrence of at least one
cytomegaly-associated ultrasound marker. The ultrasound
markers related to cytomegaly included ventriculomegaly, hy-
drocephaly, and fetal hydrops, as well as intrauterine growth
restriction (IUGR), ascites, pericardial effusion, cardiomegaly,
and hyperechogenic foci in various organs.
All the women included the study had serological features
of a possible recent infection with HCMV, identified during
pregnancy. The patients with determined specific IgM as well
as low IgG avidity were suspected as primary infected with
HCMV. The kinetics of specific IgG were analyzed to deter-
mine the occurrence of the infection as well. The preliminary
diagnosis was also based on disease-related clinical features,
including flu-like symptoms in the pregnant women and new-
borns, as well as ultrasound markers observed in the fetuses
and neonates. Active infection in pregnant women was con-
firmed by the presence of HCMV DNA in body fluids, in-
cluding blood and urine. Regarding the fetuses, viral DNA
was identified in amniotic fluids/cells, umbilical cord blood,
or ascitic fluids, while in neonates it was identified in blood or
urine specimens, as well as samples of the brains, kidneys, and
livers in the fatal cases. Data about the genotypes and DNA
loads of HCMV, determined in the body fluids of two fetuses
and newborns, have been published in our recent paper [4].
Serological tests
Blood samples from the pregnant women were taken by
venipuncture during their visit to the institute between the
8th and 39th week of gestation and from infants within a
day of birth. Serum fractions were obtained by centrifugation
and stored at 4°C until analysis. Serological tests were per-
formed at the Department of Clinical Microbiology of the
Polish Mother’s Memorial Hospital.
Between the years 2009 and 2011, the screening for
HCMV IgG and IgM antibodies and for IgG avidity was
performed by the chemiluminescence immunoassay (CLIA),
using anti-CMV IgG and IgM tests (DiaSorin/Biomedica,
Italy). Samples were considered as IgG- or IgM-positive for
antibody levels ≥0.6 IU/ml and ≥30 IU/ml, respectively. The
IgG avidity with indexes <0.200 was interpreted as low,
0.200–0.300 as borderline, and ≥300 as high. From the year
2012, the CLIA method was replaced by the enzyme-linked
fluorescence assay (ELFA). IgG antibody levels ≥6 IU/ml and
IgM indexes ≥0.9 were considered positive. The pregnant
women were suspected as HCMV-infected in case of IgG
seroconversion during pregnancy, IgM seropositivity, and
low IgG avidity index. In those patients, the presence of viral
DNAwas determined by a real-time quantitative polymerase
chain reaction (Q PCR) assay for the viral UL55 gene in
blood, urine, and amniotic fluids.
DNA isolation
HCMV DNA was extracted from maternal whole blood,
plasma, peripheral blood mononuclear cells (PBMCs),
and urine. For the studies of congenital infections, viral
DNA was isolated from amniotic and ascitic fluids of
the fetuses, as well as from plasma, whole blood, and
urine of the newborns. In the fatal cases, autopsy was
performed, followed by an analysis of DNA, purified
from fragments of brains, kidneys, and livers, stored as
paraffin-embedded tissues. Total DNA from all the clin-
ical specimens was extracted with a QIAamp DNA Mini
Kit (Qiagen, Hilden, Germany). The concentration and
purity of extracted DNA were assessed by spectropho-
tometry, using a NanoDrop ND-1000 Spectrophotometer
(NanoDrop Technologies, Inc., Wilmington, DE, USA).
Quantification of HCMV DNA
The amount of HCMV DNA in the clinical samples was
determined by the real-time Q PCR assay for the detection
ofUL55 gene fragment, as described previously [22, 23]. The
reactions were done in triplicate and the PCR conditions were
as follows: initial activation for 10 min at 95 °C and 50 cycles
of repeated denaturation at 95 °C for 15 s and annealing at
60 °C for 1 min. The standard curves, used in the quantitative
analyses, were obtained from serial 10-fold dilutions from 105
to 1 HCMV DNA copy. The amplification was performed by
a 7900HT Fast Real-Time PCR System (Applied Biosystems,
USA). HCMV DNA determination was performed for one to
five different types of samples for each patient suspected to be
infected with the virus during pregnancy, according to the
availability of the clinical materials.
HCMV glycoprotein B genotyping
Four UL55 genotypes of HCMV were distinguished by
the real-time PCR assay, using previously described
primers and probes [24]. The PCR conditions were as
follows: initial denaturation for 20 s at 95 °C and 40
cycles of repeated denaturation at 95 °C for 3 s and
annealing at 60 °C for 30 s. The real-time PCR assays
were performed using the 7500 Fast Real-Time PCR
System (Applied Biosystems, USA). In all reactions,
the serial dilutions of HCMV reference strains Towne
(gB1; ATCC: VR-977) and AD-169 (gB2; ATCC: VR-
538) were included to plot calibration curves. HCMV
DNA extracted from one to five different types of
clinical specimens for each of the patients was used
for viral genotyping, depending on the presence of viral
DNA determined by the real-time Q PCR assay.
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Statistical analysis
The distribution of particular gB genotypes of HCMV, ob-
served in pregnant women, their fetuses, and newborns, was
assessed by means of descriptive statistics. The relationships
betweenHCMV genotypes, identified in pregnant women and
genotypes, determined in fetuses and neonates, as well as
those between the viral genotype and the fetal outcome of
the disease, were estimated using cross-tabulation and
Pearson’s Chi-squared or Fisher’s exact tests. All the results
were defined as statistically significant at the significance
level of p≤0.050. The data were analyzed using the NCSS
97 software.
Results
HCMV UL55 genotypes among pregnant women and their
fetuses and neonates
In maternal body fluids, there were identified four main UL55
genotypes of HCMV. The gB1, gB2, and gB3 genotypes were
determined in whole blood, plasma, PBMCs, and urine spec-
imens, while the gB4 genotype was found only in urine.
Considering whole blood, the single gB1 genotype was ob-
served in 10.0 % (1/10) of HCMVDNA-positive samples and
gB2 in 80.0 % (8/10), while multiple gB2–gB3 genotypes
were observed in 10.0 % (1/10). In plasma, the single gB2
genotype was observed in 50.0 % of women (2/4), while
multiple gB1–gB2 or gB2–gB3 genotypes were observed in
25.0 % (1/4). In PBMCs, the single gB2 genotype was present
in 60.0 % of patients (3/5) and gB3 in 20.0 % (1/5), while
multiple gB1–gB2 genotypes were observed in 20.0 % (1/5).
Of all HCMV-positive urine samples, 64.3% (9/14) possessed
the single gB2 genotype and 14.3 % (2/14) possessed the
single gB4 or multiple gB1–gB2 genotypes, while 7.1 %
(1/14) possessed multiple gB2–gB3 genotypes.
Taking into account the all HCMV-positive pregnant wom-
en, infections with single HCMV genotypes were observed in
77.8 % (14/18), while mixed infections were observed in 22.2
% (4/18) of the study population (see Table 1). Taking into
account maternal viral genotypes, the highest incidence was
determined for the gB2 genotype, identified in 61.1% (11/18),
and there were lower incidence rates for the gB4 and gB3
genotypes, observed in 11.1 % (2/18) and 5.55% (1/18) of the
pregnant women, respectively. Among the mixed infections,
viral gB1–gB2 genotypes were noticed in 16.7 % (3/18),
while the gB2–gB3 genotypes were found in 5.55 % (1/18)
of the pregnant women. Considering the single and mixed
infections together, the gB2 genotype was identified in 77.8%
(14/18) of women and gB1 in 16.7 % (3/18), while both gB3
and gB4 were observed in 11.1 % (2/18). Of seven pregnant Ta
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women with assessed HCMV genotypes in their fetuses and
newborns four had the gB2 genotype, two had gB1–gB2
genotypes, and one had gB2–gB3 genotypes (see Table 2).
Four fetuses of the mothers infected with the gB2 genotype of
HCMV revealed the same genotype. Similar results were
observed in the triplets of one mother and in another fetus of
a different mother, both mothers being infected with multiple
HCMV gB1–gB2 genotypes. The fetus of the mother with
multiple gB2–gB3 genotypes had only the gB2 genotype.
However, the gB3 genotype was found in the maternal body
fluids (plasma, whole blood, urine) of another pregnant wom-
an after gB2 genotype identification in the amniotic fluid.
HCMV genotypes identified in the pregnant women were
estimated to have significantly determined the viral genotypes
congenitally acquired by the fetuses (p≤0.050; see Table 2).
HCMV UL55 genotypes in fetal and neonatal infections
In the infected fetuses and newborns, the gB1, gB2, and gB3
genotypes of HCMVwere observed in various studied clinical
specimens. Taking into account the amniotic fluids, the single
gB2 genotype was determined in 75.0 % (6/8) of HCMV-
positive specimens, while the multiple gB1–gB2 or gB2–gB3
genotypes were observed in 12.5 % (1/8). Of two HCMV-
positive ascitic fluids, the first possessed the gB2 genotype
and the second possessed the multiple gB1–gB2 genotypes.
All three analyzed whole-blood and one urine samples carried
the multiple gB1–gB2 genotypes. Of two plasma specimens,
the first possessed the single gB2 genotype and the second
possessed the multiple gB1–gB2 genotypes. Most fetuses and
neonates had the sameHCMVgenotype identified in all of the
analyzed samples. Comparison of the distribution of single
versus multiple HCMV genotypes between distinct clinical
specimens showed a marginally significant difference (χ2=
15; p=0.0592). The multiple viral genotypes were significant-
ly more frequent in fetal and neonatal body fluids than in
tissue fragments [100.0 % (8/8) vs. 0.0 % (0/8); p≤0.050;
Fisher’s exact test].
Of all congenital infections, half (6/12) were caused by
single HCMV genotypes and the other half by multiple geno-
types (see Table 1). A single gB1 genotype was determined in
11.1 % (1/9) of the fetuses but not in any of the newborns. The
gB2 genotype was identified in 66.7 % (6/9) of the fetuses and
in 20.0 % (1/5) of the newborns. Coinfections with the gB1–
gB2 genotypes of HCMV were determined in 11.1 % (1/9)
and 80.0 % (4/5) of the fetuses and newborns, respectively.
Mixed infections with the gB2–gB3 genotypes were observed
in 11.1 % of the fetuses. In contrast, this type of infection was
identified in none of the newborns included in the study.
Taking into account the single and mixed infections together,
both gB1 and gB2 genotypes of HCMV were determined in
50.0 % (6/12) of the congenitally infected fetuses and new-
borns, while gB3 was observed in 8.3 % (1/12) of cases.
Cytomegaly outcome in fetuses and newborns with distinct
HCMV genotypes
Among all fetal and neonatal infections, 50.0 % (6/12) were
asymptomatic and the other 50.0 % were symptomatic (see
Table 1). The fetuses and newborns with asymptomatic
cytomegaly had single gB1, gB2, or multiple gB1–gB2 geno-
types. Two cases (33.0 %) were infected with a single HCMV
gB2 genotype, while four (66.7 %) were infected with multi-
ple gB1–gB2 genotypes. The fetuses and neonates with symp-
tomatic disease had all three HCMV genotypes determined.
Among them, a single gB2 genotype was identified in 50.0 %
(3/6) of cases, while the gB1 genotype was identified in 16.66
% (1/6). Mixed infections with the gB1–gB2 or gB2–gB3
genotypes of HCMV were determined in 16.66 % of the
fetuses and newborns for each type of infection.
Discussion
Intrauterine HCMV infections and congenital cytomegaly are
caused by four gB genotypes of HCMV [19, 25, 26]. In this
reported study, we identified HCMV gB1, gB2, and gB3
genotypes in some Polish fetuses and newborns. Similarly,
congenital infections among Costa Rican, Indian, and Chinese
infants were caused by the same three viral genotypes
[26–28]. Studies performed in HCMV-infected newborns
and infants from Southern Poland revealed the occurrence of
gB1, gB2, gB3, and gB4 viral genotypes in 43.7 %, 31.25 %,
25 %, and 12.5 % of children, respectively [14]. In our study,
we observed slightly higher incidence rates of gB1 and gB2
genotypes (50.0 %) and lower rates for the gB3 genotype (8.3
%), while no gB4 genotype was found among either the
fetuses or the newborns. Similar frequencies of HCMV geno-
types were reported also for Costa Rican and Indian infants
[20, 27]. Differences observed between our results and the
Table 2 Relationship between HCMV genotypes identified in the preg-
nant women and their offspring
Maternal genotype Fetal and neonatal genotype Total
gB2 gB1–gB2
gB2 4 0 4
gB1–gB2 0 4 4
gB2–gB3 1 0 1
Total 5 4 9
χ2 =9
p ≤ 0.050
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results of the study of newborns and infants from Southern
Poland may not be significant, since both study groups were
relatively small. Therefore, research would be justified with a
larger group of fetuses, newborns, and infants. In contrast, the
recent study of newborns fromCentral Poland demonstrated gB2
to be the major genotype (96 %) of HCMV among infected
neonates [4]. Since the samples used in both studies included
offspring born in the same hospital during a similar period of
time, we suggest different sensitivity of methods as well as
variety of types of clinical materials used in the described re-
search for the determination of HCMV genotypes as the main
reasons for the discrepancies observed [4, 24]. In our study, most
cases of the gB1 genotype of HCMV (83.3%, five of six cases)
were involved in mixed infections with gB1–gB2 genotypes.
Taking into account the ability of direct sequencing to select one
strain only, it seems possible that, in such cases, the previously
adapted method could also find only a single gB2 strain of
HCMV [24]. However, comparison of the results obtained for
two offspring analyzed in both our studies showed that different
genotypes identified might come from the different types of
clinical materials used as well. For two mentioned fetuses, the
current study showed the presence of HCMV gB1–gB2 or gB2–
gB3 multiple genotypes in urine specimens or amniotic/ascitic
fluids, respectively. In turn, the previous study performed for
neonatal blood samples collected on the day of birth reported that
investigated offspring were infected with the viral gB2 or gB3
genotypes, respectively [4]. Therefore, the use of assays with the
highest sensitivity and various clinical specimens seems to be
necessary to determine the whole spectrum of HCMVgenotypes
related to congenital infections.
The incidence rates of gB1 and gB2 genotypes observed in
our study group of fetuses were higher when compared to the
rates of congenital infections in France or India [21, 26]. In turn,
compared with data for congenital infections reported for
American infants, the incidence of the gB1 genotype of
HCMVwas the same [19]. Based on our results and the literature
data, the genotypic variability of HCMV seems to be geograph-
ically related. Besides single infections, several studies conducted
for theUnited States, theNetherlands, Poland, andChina showed
the occurrence of congenital infections with multiple HCMV gB
genotypes [14, 29–31]. The rates of mixed infections varied from
approximately 2 % in Chinese to 45 % in American infants [31,
32]. In Poland, infections with multiple HCMV gB genotypes
have been observed in 12.5 % of studied newborns [14]. In the
current study population of fetuses and newborns, mixed infec-
tionswere identified at the rate of 50.0%, being similar to that for
the American infants [32].
The mixed infections observed in our study fetuses were
caused by the viral gB1–gB2 and gB2–gB3 genotypes, while
they were caused by the gB1–gB2 genotypes in the newborns.
A Dutch study performed in adults and infants reported the
occurrence of double and triple mixed infections composed of
various gB genotypes [29].
Among American infants, mixed infections were identified
with viral gB1–gB2, gB2–gB3, as well as with gB2–gB4 geno-
types [30]. Among infected Indian infants, the gB3 genotype was
the most prevalent in symptomatic cases [26]. In turn, the gB2
genotype was more common in infants with long-term sequelae
[26]. In Chinese infants, four gB genotypes were differentially
distributed in patients with various symptoms of congenital
cytomegaly [33]. Among congenitally infected Italian babies,
HCMV disease and central nervous system (CNS) damage were
more frequent among patients with gB1 and gB3 compared to
those with gB2 and gB4 genotypes of HCMV; however, those
differences were non-significant [18]. Taking into account the
mixed infections, one study has shown no relationship between
such infections and the clinical outcome of congenital cytomegaly
[32]. Considering cytomegaly outcomes, we did not observe any
differences among the fetuses and newborns infected with single
and multiple HCMV genotypes. The small number of offspring
with congenital cytomegaly and observed disease symptoms, as
well as the uncertain significance of genotyping of a single
HCMV glycoprotein B with extensive diversity among many
other viral genes, seem to be the major causes of the observed
lack of relationships. In this study population, we demonstrated a
correlation between maternal HCMV genotypes and the viral
genotypes identified in their fetuses and neonates. A similar
relationship was also observed in Brazilian transmitting and
non-transmitting mothers and their congenitally infected infants
[34]. Similarly to other studies, we observed that the distribution
of the gB genotypes in fetuses and neonates reflected the inci-
dence of viral genotypes identified in the population of pregnant
women [34]. Comparative to congenital infections, we also
showed the gB2 and gB1–gB2 genotypes of HCMV present in
the pregnant women to be the most common causes of single and
mixed infections, respectively. No such study has yet been per-
formed for any Polish population of pregnant women.
HCMV congenital cytomegaly diagnosed in Polish fetuses
and newborns from Central Poland resulted from infections
with gB2, gB1, and gB3 viral genotypes, with a distribution
resembling the incidence rates of particular genotypes circu-
lating in pregnant women. Similarly to other populations, both
single and mixed infections may cause congenital cytomegaly,
with asymptomatic as well as symptomatic outcomes.
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